Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01397591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00303953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
ClinicalTrials.gov study NCT02309515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06765317. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01453205. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00308087. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
ClinicalTrials.gov study NCT00714259. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL
ClinicalTrials.gov study NCT05296525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02420210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
ClinicalTrials.gov study NCT04509700. IPD Sharing: YES. Countries: 17. Publications: 0.
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07223021. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00690560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participant
ClinicalTrials.gov study NCT02624986. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
ClinicalTrials.gov study NCT04257578. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01549886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01491841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00667615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03992339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
ClinicalTrials.gov study NCT01119794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03340766. IPD Sharing: YES. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.